Granulocyte macrophage colony-stimulating factor

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

<templatestyles src="Module:Infobox/styles.css"></templatestyles>

Colony stimulating factor 2 (granulocyte-macrophage)
GMCSF Crystal Structure.rsh.png
PDB rendering based on 2gmf
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols CSF2 ; GMCSF
External IDs OMIM138960 MGI1339752 HomoloGene600 GeneCards: CSF2 Gene
RNA expression pattern
PBB GE CSF2 210229 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 1437 12981
Ensembl ENSG00000164400 ENSMUSG00000018916
UniProt P04141 P01587
RefSeq (mRNA) NM_000758 NM_009969
RefSeq (protein) NP_000749 NP_034099
Location (UCSC) Chr 5:
132.07 – 132.08 Mb
Chr 11:
54.25 – 54.25 Mb
PubMed search [1] [2]
Granulocyte-macrophage colony-stimulating factor
File:PDB 1csg EBI.jpg
three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor
Identifiers
Symbol GM_CSF
Pfam PF01109
Pfam clan CL0053
InterPro IPR000773
PROSITE PDOC00584
SCOP 2gmf
SUPERFAMILY 2gmf
Granulocyte macrophage colony-stimulating factor
GMCSF Crystal Structure.rsh.png
Systematic (IUPAC) name
Human granulocyte macrophage colony stimulating factor
Identifiers
CAS Number 83869-56-1 YesY
ATC code L03AA09 (WHO)
DrugBank DB00020 N
Chemical data
Formula C639H1006N168O196S8
Molecular mass 14434.5 g/mol
 NYesY (what is this?)  (verify)

Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony stimulating factor 2 (CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts that functions as a cytokine. The pharmaceutical analogs of naturally occurring GM-CSF are called sargramostim and molgramostim.

Function

GM-CSF is a monomeric glycoprotein that functions as a cytokine - it is a white blood cell growth factor.[1] GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exit the circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection.

GM-CSF also has some effects on mature cells of the immune system. These include, for example, inhibiting neutrophil migration and causing an alteration of the receptors expressed on the cells surface.[2]

GM-CSF signals via signal transducer and activator of transcription, STAT5.[3] In macrophages, it has also been shown to signal via STAT3. The cytokine activates macrophages to inhibit fungal survival. It induces deprivation in intracellular free zinc and increases production of reactive oxygen species that culminate in fungal zinc starvation and toxicity.[4] Thus, GM-CSF facilitates development of the immune system and promotes defense against infections.

GM-CSF also plays a role in embryonic development by functioning as an embryokine produced by reproductive tract.[5]

Genetics

The human gene has been localized to a cluster of related genes at chromosome region 5q31, which is known to be associated with interstitial deletions in the 5q- syndrome and acute myelogenous leukemia. Genes in the cluster include those encoding interleukins 4, 5, and 13.[6]

Glycosylation

Human granulocyte macrophage colony-stimulating factor is glycosylated in its mature form.

Medical use

GM-CSF is manufactured using recombinant DNA technology and is marketed as a protein therapeutic called molgramostim or, when the protein is expressed in yeast cells, sargramostim. It is used as a medication to stimulate the production of white blood cells and thus prevent neutropenia following chemotherapy.[7]

GM-CSF has also been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients.[8][9]

Sargramostim

Lua error in package.lua at line 80: module 'strict' not found. Sargramostim, recombinant yeast-derived GM-CSF developed at Immunex (now Amgen) and first given to six humans in 1987 as part of a compassionate-use protocol for the victims of cesium irradiation from the Goiânia accident.[10] It was originally developed by Immunex. When Amgen bought Immunex, sargramostim was divested to Berlex, a US subsidiary of Schering AG. Berlex was acquired by Bayer in 2006, and Bayer sold the franchise to Genzyme in 2009, which was subsequently acquired by Sanofi.[11] Its use was approved by U.S. Food and Drug Administration for acceleration of white blood cell recovery following autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma, acute lymphocytic leukemia, or Hodgkin's disease in March 1991.[12] In November 1996, the FDA also approved sargramostim for treatment of fungal infections and replenishment of white blood cells following chemotherapy.[13]

Rheumatoid arthritis

GM-CSF is found in high levels in joints with rheumatoid arthritis and blocking GM-CSF may reduce the inflammation or damage. Some drugs (e.g. MOR103) are being developed to block GM-CSF.[14]

See also

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. Lua error in package.lua at line 80: module 'strict' not found.
  4. Lua error in package.lua at line 80: module 'strict' not found.
  5. Lua error in package.lua at line 80: module 'strict' not found.
  6. Lua error in package.lua at line 80: module 'strict' not found.
  7. Lua error in package.lua at line 80: module 'strict' not found.
  8. Lua error in package.lua at line 80: module 'strict' not found.
  9. Lua error in package.lua at line 80: module 'strict' not found.
  10. Lua error in package.lua at line 80: module 'strict' not found.
  11. Stewart Lyman for Xcocomy. June 11, 2010 Biotech Drug Discovery in Seattle: A Look Back
  12. Lua error in package.lua at line 80: module 'strict' not found.
  13. Lua error in package.lua at line 80: module 'strict' not found.
  14. Lua error in package.lua at line 80: module 'strict' not found.

External links